The company touts FineVision HP as the world’s first trifocal IOL, bringing in a new era of premium IOL offerings. FineVision HP features a patented diffractive optic design, delivery balanced vision at far, intermediate and near distances.

Christophe Pagnoulle, BVI’s R&D director, and Dr. Damien Gatinel, an ophthalmologist, brought FineVision HP to market. The company says its latest milestone reinforces its leadership in premium IOLs, expanding advanced vision solutions for U.S. patients.

“The development of FineVision HP was a pivotal moment for ophthalmology, reshaping expectations for vision correction after cataract surgery,” said Gatinel. “FDA approval in the U.S. means even more patients will benefit from this breakthrough technology.”